To investigate the role of the P2Y6 receptor in AAA formation, 16~32 mg MRS2578, the specific P2Y6 receptor antagonist, or vehicle was administrated via intraperitoneal injection 1 week before Ang II infusion. This evidence concerns the gene AGT and triple-A syndrome.